FDA Approves TMS Therapy to Treat OCD | 合法醫療器材資訊網

2020年8月11日—MagVentureTMSTherapycanbeusedasadjunctivetherapytootherOCDtreatments....TheUSFoodandDrugAdministration(FDA)hasapproved ...

The US Food and Drug Administration (FDA) has approved transcranial magnetic stimulation (TMS Therapy) for adjunct treatment in adult patients with obsessive-compulsive disorder[1].

TMS had previously been granted approval to MagVenture for the treatment of major depressive disorder[2] in patients who failed to experience adequate improvement from use of antidepressant medication. The company was the first to receive FDA clearance for the 3-minute Express TMS—the shortest TMS treatment now available.

Now, the out-patient procedure can be used as adjunctive to other OCD treatments that might involve pharmaceutical and behavioral therapy. Using magnetic pulses to stimulate specific areas in the brain, TMS targets its networks and deeper-lying structures that are known to be particularly affected by OCD.